InPlay: Cell Genesys reports "encouraging" interim data from phase 1 clinical trial of CG0070 in...

yahoo.com     May 21, 2008            

8:58AM S&P futures vs fair value: +1.0. 8:55AM Eaton Vance reports EPS in-line, misses on revs; Assets up 4% sequentially 40.50 : Reports Q2 (Apr) earnings of $0.43 per share, in-line with the First Call consensus of $0.43; revenues rose 5.1% year/year to $273.4 mln vs the $277.7 mln consensus.... [read full story]                    


*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies